Disease-associated autoimmunity and prevention of insulin-dependent diabetes mellitus

Annals of Medicine

Volumn 29, Issue 5, 1997, Pages 447-451

  Knip, Mikael ^a,b,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

Autoantibodies; Autoimmunity; Prediabetes; Prevention; T cell responses

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN; PANCREAS ISLET CELL ANTIBODY;

ARTICLE; AUTOIMMUNITY; HUMAN; HUMORAL IMMUNITY; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030710550     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899708999375     Document Type: Article

References (26)

1. Cooke A. An overview on possible mechanisms of destruction of the insulin-producing β cell. Curr Top Microbiol Immunol 1990; 164: 125-42.
2. Thai AC, Eisenbarth GS. Natural history of IDDM. Diabetes Rev 1993; 1: 1-14.
3. Davies JL, Kawaguchi Y, Bennett ST, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371: 130-6.
4. Hashimoto L, Habita C, Beressi JP, et al. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 1994; 371: 161-4.
5. Atkinson A, Kaufman D, Campbell L, et al. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 1992; 339: 458-9.
6. Harrison LC, Honeyman MC, DeAizpurua HJ, et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993; 341: 1365-9.
7. Duronovic Bello I, Hummel M, Ziegler AG. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 1996; 45: 795-800.
8. Dahlquist GG, Ivarsson S, Lindberg B, Forsgren M. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study. Diabetes 1995; 44: 408-13.
9. Hyöty H, Hiltunen M, Knip M, et al. A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 1995; 44: 652-7.
10. Petersen JS, Kyvik KO, Bingley PJ, et al. Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus. BMJ 1997; 314: 1575-9.
11. Martikainen A, Kulmala P, Savola K, et al. Autoantibodies to islet cells (ICA) and glutamic acid decarboxylase (GADA) during pregnancy and at birth in diabetic families. J Pediatr Endocrinol Metabol 1997; 10: 343 (Abstr).
12. Martikainen A, Saukkonen T, Kulmala PK, et al. Disease associated antibodies in offspring of mothers with IDDM. Diabetes 1996; 45: 1706-10.
13. Simell O, Simell T, Muona P, et al. Seroconversion to autoantibody positivity of children at genetic risk for insulin-dependent diabetes. Diabetologia 1997; 40 (Suppl 1): A79 (Abstr).
14. Knip M, Kulmala P, Petersen JS, et al. Evolution of islet cell associated autoimmunity in preclinical IDDM. Diabetologia 1995; 38 (Suppl 1): A88 (Abstr).
15. + relatives. Diabetes 1996; 45: 1720-8.
16. Christie MR. Islet cell autoantigens in type 1 diabetes. Eur J Clin Invest 1996; 26: 827-38.
17. Kaufman DL, Clare-Salzer M, Tian J, et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366: 69-72.
18. Tisch R, Yang X-D, Singer SM, Liblau RS, Fuggert L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993; 366: 72-5.
19. Yu L, Rewers M, Gianini R, et al. Anti-islet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab 1996; 81: 4264-7.
20. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to differential functional properties. Annu Rev Immunol 1989; 7: 145-73.
21. DelPrete GF, De Carli M, Ricci M, Romagnani S. Purified protein derivate of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991; 88: 346-50.
22. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16: 34-8.
23. Adojaan B, Knip M, Vähäsalo P, Karjalainen J, Kalits I, Åkerblom HK. Relationship between the incidence of childhood IDDM and the frequency of ICA positivity in nondiabetic children in the general population. Diabetes Care 1996; 19: 1452-4.
24. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes 1994; 43: 613-21.
25. Kulmala P, Savola K, Petersen JS, et al. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes - a population-based study. J Clin Invest (in press).
26. Knip M, Rahko J, Kulmala P, Vähäsalo P, Karjalainen J. Occurrence and persistence of IDDM-associated autoantibodies in unaffected school children. Diabetologia 1996; 39 (Suppl 1): A46 (Abstr).